Glucose
Health, Inc. 2019
ANNUAL
REPORT –
Revenue
Growth
47%
BENTONVILLE, AR --
February 3, 2020 -- InvestorsHub NewsWire
-- Glucose Health, Inc.
(OTC:
"GLUC")
confirms
the
following selected financial data for the
2019
fiscal year ended
December
31, 2019,
posted
today
at OTCMarkets.com.
1)
Fiscal
2019 Revenue of
$291,213
compared
with $197,500
for
Fiscal
2018;
a
47% year-over-year
increase.
2)
GLUCODOWN® sales at
Walmart up 28% year-over-year,
2019 vs.
2018.
3)
GLUCODOWN® sales at
Amazon up 224%
year-over-year,
2019 vs.
2018.
4)
Total
Debts
& Liabilities
of
$380,652
at
December
31, 2019,
vs.
$559,995
at December
31,
2018; a
32% reduction.
Murray Fleming, CEO
of Glucose Health, Inc., stated, "Glucose Health, Inc.
has
five
strategic
goals for
fiscal
2020:
1)
Amazon
Growth.
Amazon
is
the
fasting
growing distribution
channel and key
to
achieving
GLUCODOWN®
sales revenue
targets
in
2020.
2)
More
Pharmacy
Retailer
Partnerships.
We are in
active pursuit of shelf space at national
pharmacy
retailers to
further
increase
distribution of
GLUCODOWN®.
3)
Direct
Response Sales.
Establish
a direct response sales channel with toll-free
number plus
expanded
TV advertising on Hallmark, Game Show Network National Geographic
and new for 2020, Fox News Channel
4)
Additional
Line
Extensions.
Introduce
differentiated
container
sizes
for all
four flavors of GLUCODOWN® tailored to
individual
distribution
channels;
smaller
containers
for
budget retailers; larger containers
for
full-service pharmacy retailers.
5)
Increase
Profit
Margins
by
50%.
Increase
profit margin by 50%
through
improved
production
methods
and cost-control
and selected
retailer
product
price increases."
GLUCODOWN®
offers
consumers
an
unbeatable combination of benefits in the adult
nutrition/diabetes
care
retail
category:
-
Nutrition:
GLUCODOWN®
contains
a
unique
form
of soluble fiber
which,
77
clinical studies1
indicate,
can
be
associated
with beneficial
impacts on
blood
glucose,
triglycerides, cholesterol and
digestive
health.
-
Holistic:
GLUCODOWN®
contains
Banaba
leaf;
a plant
native to India,
where
in Ayurvedic
medicine, it is
deemed
a
holistic blood sugar remedy. The
insulin-like
effect
has been
suggested
in
scientific research, to
be
related to corosolic
acid,
a substance naturally
present
in Banaba
leaf.2
-
Value:
GLUCODOWN®
Diabetic
Friendly
Tea
Mix combines
$49.07 of
premium
vitamins,
minerals, plant extracts and soluble fiber, sold individually by
other manufacturers,
together
in
one unique
product
for the
first time – thereby
offering
consumers unparalleled value-for-money.3
About
Glucose Health, Inc. (OTC:
GLUC)
Manufactured by
Glucose Health, Inc.,
GLUCODOWN®
is
a
delicious iced tea beverage
specifically
formulated for the adult nutrition/diabetic
supplies
retail
category.
More
than 100 million
Americans are
estimated
to be diabetic or pre-diabetic, by the Centers for Disease Control
and Prevention.4
GLUCODOWN® is a
unique and compelling healthy
drink
choice and
is
the
first iced
tea mix enriched with
soluble fiber.
Glucose
Health, Inc. is a publicly traded company with
the ticker symbol OTC:
GLUC.
1,2For
citations see www.glucodown.com/clinical-data
3$49.07 = (Amazon
Survey 2018-11-15)
4National Diabetes
Statistics Review, 2019; Centers for Disease
Control and Prevention, Department of Health and Human
Services.
Contact:
Murray
Fleming
Glucose Health,
Inc.
(479)
802-3827